Assessing harmful effects in systematic reviews

BMC Medical Research Methodology

Volumn 4, Issue , 2004, Pages

  McIntosh, Heather M ^a   Woolacott, Nerys F ^a   Bagnall, Anne Marie ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DELAYED RELEASE FORMULATION; NEUROLEPTIC AGENT; NICOTINE;

CLINICAL TRIAL; COMPARATIVE STUDY; DATA ANALYSIS; DECISION MAKING; EPILEPSY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NICOTINE REPLACEMENT THERAPY; QUALITY CONTROL; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SMOKING CESSATION; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; DELAYED RELEASE FORMULATION; ECONOMICS; META ANALYSIS (TOPIC); OBSERVATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; TREATMENT OUTCOME;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BUPROPION; DELAYED-ACTION PREPARATIONS; HUMANS; META-ANALYSIS AS TOPIC; NICOTINE; OBSERVATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SCHIZOPHRENIA; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 4844229862     PISSN: 14712288     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2288-4-19     Document Type: Review

References (29)

1. Ernst E, Pittler MH: Assessment of therapeutic safety in systematic reviews: literature review. BMJ 2001, 323:546.
2. Ioannidis JPA, Lau J: Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001, 285:437-443.
3. Loke YK, Derry S: Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol 2001, 1:3.
4. Cuervo GL, Clarke M: Balancing benefits and harms in health care. BMJ 2003, 327:65-66.
5. Aronson JK, Derry S, Loke YK: Adverse drug reactions: keeping up to date. Fundam Clin Pharmacol 2002, 16:49-56.
6. Cochrane Adverse Effects Sub-Group of the Cochrane Non-Randomised Study Methods Group: Including adverse effects in systematic reviews: interim recommendations. [http://www.dsru.org/wwwboard/latestdraft.pdf].
7. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowdon AJ, Song FJ, Raftery JP, Aveyard PN, Hyde CJ, Barton PM: The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002, 6 (16):1-245.
8. Bagnall A-M, Jones L, Ginnelly L, Lewis R, Glanville J, Gilbody S, Davies L, Torgerson D, Kleijnen J: A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 2003, 7 (13):1-193.
9. Wilby J, Kainth A, McIntosh HM, Forbes C: The clinical effectiveness and cost-effectiveness of newer drugs for epilepsy in adults. Health Technol Assess, in press.
10. Derry S, Loke YK, Aronson JK: Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol 2001, 1:7.
11. Bagett R, Chiquette E, Anagnostelis B, Mulrow C: Locating reports of serious adverse drug reactions [poster]. Proceeding of the 7th Annual Cochrane Colloquium: October 1999; Rome.
12. Golder S, McIntosh HM, Duffy S, Glanville J: Developing efficient search strategies to identify papers on adverse events. In: Abstract Book HTAi 1st Annual Meeting: May-June 2004; Krakow.
13. Golder S, Duffy S, Glanville J, McIntosh HM, Miles J: Designing a search filter to identify reports of adverse events. In: Abstract Book HTAi 1st Annual Meeting: May-June 2004; Krakow.
14. Lewis S: Cost utility of the latest antipsychotics in severe schizophrenia (CUtLASS): a multi-centre, randomised, controlled trial. Health Technol Assess, in press.
15. Martindale: The Complete Drug Reference. 33rd edition. Edited by: Sweetman SC. London, Pharmaceutical Press; 2002.
16. Dukes MNG, Aronson JK: Meyer's side effects of drugs: an encyclopedia of adverse reactions and interactions. Oxford, Elsevier; 2000.
17. Loke YK, Derry S: Incorporating adverse effects data into reviews: how to get started [abstract]. 9th Annual Meeting for UK Contributors to the Cochrane Collaboration: 2003; Coventry.
18. Medawar C, Herxheimer A: A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 2004, 16:5-19.
19. Juni P, Altman DG, Egger M: Assessing the quality of randomised controlled trials. Systematic Reviews in Health Care Meta-analysis in context 2nd edition. Edited by: Egger M, Smith GD and Altman DG. London, BMJ; 2001.
20. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG: Evaluating non-randomised intervention studies. Health Technol Assess 2003, 7 (27):1-173.
21. Downs S, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52:377-384.
22. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J: Methodological index for non-randomised studies (MINORS): development and validation of a new instrument. ANZ J Surg 2003, 73:712-716.
23. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. [[http://www.ohri.ca/programs/clinical_epidemology/oxford. html].
24. Glasziou P, Vandenbroucke J, Chalmers I: Assessing the quality of research. BMJ 2004, 328:39-41.
25. WHO Collaborating Centre for International Drug Monitoring: Definitions [http://www.who-umc.org/defs.html]
26. Silagy C, Mant D, Fowler G, Lancaster T: Nicotine replacement therapy for smoking cessation (Cochrane Review). The Cochrane Library Oxford, Update Software; 2001.
27. Mann RD: Prescription-event monitoring - recent progress and future horizons. Br J Clin Pharmacol 1998, 46:195-201.
28. Centre for Reviews and Dissemination: Undertaking systematic reviews of research on effectiveness. Edited by: Khan SK, ter Riet G, Glanville J, Sowden AJ and Kleijnen J (Eds). York, University of York; 2001.
29. Crombie IK: The Pocket Guide to Critical Appraisal. London, BMJ Publishing Group; 1996.